ARCHIVES

In Brief: Bristol To Drop Angiostatin; Protein Fails To Meet Criteria For Development, Firm Says

This article is from The Cancer Letter archive.

Vol. 25 No. 06 | February 12, 1999

Download PDF Visit The Full Archive

Related Articles

Network Should Collect Some Environmental Information: Collins

August 9, 1996

ACS Funds Pilot Study Of Mammography Trial

July 28, 1995

Some NCI Advisors Tell GAO Congress “Jumped The Gun” In Creating Cancer Control Program

October 26, 1979

FDA Guidance for Public Comment at Advisory Committee Meetings

December 10, 2010

NCI, FDA Courting Drug Sponsors To Add Clinical Trials To PDQ Database

October 11, 1996

The Meeting Worth Lobbying For: A “PRG” For Disease-Specific Review; NCI Plans Six.

June 23, 2000